Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Psy104 - Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions

Value in Health

English

Pdb82 - Re-Analysis of the Diabetes Prevention Program (Dpp) 3 Year Cost-Effectiveness Analysis (Cea) Using Identical Data but Proper Qaly Calculations May Revive Its Metformin Conclusions

English

Pih14 - Factors Associated With the Use of Antipyretics in Children of Parents in a Cohort Sample in Saudi Arabia

English

Psy57 - A Comparison Between on Demand Usage of Rfviia vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; A Cost Utility Analysis

English

Psy105 - Cost-Utility of Nintedanib Versus Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis: A Belgian Perspective

English

Psy170 - Impact of Multiple Indications on Price and Access of Drugs for Autoimmune Diseases

English

Prm106 - Advanced Nma Techniques in Nice Hta Submissions

English

Prm154 - Modeling Migraine Day Frequency by Responder Status: A Re-Analysis of Data From Erenumab Clinical Trials

English

Php15 - New Treatment Methods and Reimbursement: Experiences in Germany 2018

English

Pcn36 - The Effect of Introducing Nivolumab in the Adjuvant Treatment Setting of Malignant Melanoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Psy104 - Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions

Pdb82 - Re-Analysis of the Diabetes Prevention Program (Dpp) 3 Year Cost-Effectiveness Analysis (Cea) Using Identical Data but Proper Qaly Calculations May Revive Its Metformin Conclusions

Pih14 - Factors Associated With the Use of Antipyretics in Children of Parents in a Cohort Sample in Saudi Arabia

Psy57 - A Comparison Between on Demand Usage of Rfviia vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; A Cost Utility Analysis

Psy105 - Cost-Utility of Nintedanib Versus Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis: A Belgian Perspective

Psy170 - Impact of Multiple Indications on Price and Access of Drugs for Autoimmune Diseases

Prm106 - Advanced Nma Techniques in Nice Hta Submissions

Prm154 - Modeling Migraine Day Frequency by Responder Status: A Re-Analysis of Data From Erenumab Clinical Trials

Php15 - New Treatment Methods and Reimbursement: Experiences in Germany 2018

Pcn36 - The Effect of Introducing Nivolumab in the Adjuvant Treatment Setting of Malignant Melanoma